benazepril hydrochloride and hydrochlorothiazide
BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE (benazepril hydrochloride and hydrochlorothiazide) by Novartis is mechanism of action benazepril and benazeprilat inhibit angiotensin-converting enzyme (ace) in human subjects and in animals. Approved for thiazide diuretic [epc]. First approved in 2004.
Drug data last refreshed 20h ago
Mechanism of Action Benazepril and benazeprilat inhibit angiotensin-converting enzyme (ACE) in human subjects and in animals. ACE is a peptidyl dipeptidase that catalyzes the conversion of angiotensin I to the vasoconstrictor substance, angiotensin II. Angiotensin II also stimulates aldosterone…
Worked on BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE at Novartis? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Thiazide Diuretic
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.